title: [Neurocysticercosis: pediatric aspects].
abstract: Neurocysticercosis is the most frequent parasitosis of the central nervous system in the world. Due to the extension of the pandemy, and the importance of the migrations from endemic countries, this parasitosis is being diagnosed with increasing frequency in France. Epilepsy is the main revealing symptom. However, in endemic countries, neurocysticercosis should be suspected in patients with any neurological sign. Diagnosis is based upon imaging procedures (computed tomography and magnetic resonance imaging) and serology (Elisa and Western blot). The evolution is highly variable, from complete latency to severe encephalopathy with psychomotor regression. Praziquantel and albendazole are the main therapeutic agents. Although corticosteroids are usually very effective on symptoms of the acute phase of the disease, their place in the treatment remains to be clarified. Racemic and ventricular forms of the disease usually need neurosurgery. In endemic regions, the diminution of the frequency of the disease relies upon prevention through health education compaigns, pending the achievement of an efficient vaccine.
authors: Service de pédiatrie, centre hospitalier de Soavinandriana, Antananarivo, Madagascar.
authors: J
authors: J
authors: Grill
authors: P
authors: P
authors: Pillet
authors: W
authors: W
authors: Rakotomalala
authors: A
authors: A
authors: Andriantsimahavandy
authors: P
authors: P
authors: Esterre
authors: P
authors: P
authors: Boisier
authors: P
authors: P
authors: Guyon
mesh_terms: D002493:Central Nervous System Diseases / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D002648:Child; D003551:Cysticercosis / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D006801:Humans
vernacular_title: La neurocysticercose: particularités pédiatriques.